Milestone 4, page-132

Pretty sure this is just a troll but nothing has been said that I'm aware of that isn't already known to the market. M4 is on track and Spikenet was a lucrative acquisition. They are outlined in the announcements.

BrainChip just needs a good CEO and a good M4 deal to gain validation of its technology and management capabilities.

RAP (not cross-promoting) is very similar to BRN.

Both are big ideas with no revenue.

RAP technology is validated through trials and awards (still waiting on FDA approval) while BRN hasn't had any commercial validation and minimal research validation.

RAP is not expecting revenue this year and there are no guidelines for next year. BRN is expecting revenue this year.

The reason why RAP is sitting on a ~$300M valuation is because it's received validation from trials, awards and management executing time lines.

BRN's validation stems from capable CEO, sizable license agreement and other validation such as press and uproar in the tech community.

We are again in the thick end of substantial announcements coming our way. Validation is coming, CEO and M4 should be coming anywhere between the next 4 months.

Then BRN can go back to a fair valuation in the hundreds of millions and there will be very happy shareholders.